A new study has shed light on the effectiveness of ketamine as a treatment for severe depression, particularly among veterans who have struggled with traditional treatments.
This research was conducted by a team at the University of Michigan and VA Ann Arbor Healthcare System. It focused on veterans who had not found relief from other forms of depression treatment.
The study observed 215 veterans who received ketamine infusions at various Veterans Affairs hospitals. Remarkably, almost half of these veterans experienced a notable decrease in their depression symptoms after six weeks of treatment.
About a quarter saw their depression scores halve, and 15% reached full remission, indicating a big recovery from their depressive state.
This is a remarkable finding considering the complex mental health needs of these veterans.
Before turning to ketamine, these individuals had attempted multiple depression treatments without success and often suffered from additional mental health challenges like post-traumatic stress disorder (PTSD), anxiety, or past substance abuse.
Ketamine, primarily known as an anesthetic and sometimes misused as a recreational drug, has shown promise as a rapid-acting antidepressant.
The veterans in this study received an average of 18 ketamine infusions over several months, suggesting that ongoing treatment might be necessary for lasting benefits.
The team emphasizes that ketamine is not a cure-all.
They note that while dramatic improvements are not seen immediately or in every patient, the significant response in a substantial number of cases is promising, especially for those who have exhausted other options.
The study’s findings are important for several reasons. First, they provide real-world evidence of ketamine’s effectiveness in a clinical setting, especially for those with complex mental health issues.
This information is vital for developing treatment protocols in VA hospitals and potentially beyond.
Additionally, the study highlights the importance of multiple infusions over an extended period.
Unlike other antidepressants that require weeks to show effects, ketamine’s rapid action instills hope in patients, an essential factor in mental health recovery.
However, the researchers caution that the benefits of ketamine need to be weighed against its potential for abuse.
Patients with a history of substance use must be in stable recovery, and all patients undergo regular urine tests to ensure they are not using drugs or alcohol, which can dangerously interact with ketamine.
If you care about mental health, please read studies about 6 foods you can eat to improve mental health, and B vitamins could help prevent depression and anxiety.
For more information about mental health, please see recent studies about how dairy foods may influence depression risk, and results showing Omega-3 fats may help reduce depression.
The research findings can be found in J Clin Psychiatry.
Copyright © 2024 Knowridge Science Report. All rights reserved.
